Featured Research

from universities, journals, and other organizations

Branching Out: New System Created By Rensselaer Researchers Speeds The Mapping Of Blood Vessel Networks In Live Tumors

Date:
December 27, 2002
Source:
Rensselaer Polytechnic Institute
Summary:
Rensselaer researchers have developed an automated system, called RPI-Trace3D, that can swiftly map capillaries in a live tumor. What used to take days of manually tracing the vessels, now takes two minutes. The diagnostic tool, in use at Harvard Medical School and at Northeastern University, is a boon to oncologists who aim to understand how blood vessels form in tumors.

TROY, N.Y.- Rensselaer researchers have developed an automated system, called RPI-Trace3D, that can swiftly map capillaries in a live tumor. What used to take days of manually tracing the vessels, now takes two minutes. The diagnostic tool, in use at Harvard Medical School and at Northeastern University, is a boon to oncologists who aim to understand how blood vessels form in tumors.

For the first time, medical scientists can quickly and precisely measure blood vessel properties to quantify the effects of various agents, such as new drugs, on capillary growth. Preventing new capillaries from forming in abnormal tissue by shutting off a tumor's blood supply (angiogenesis) is a promising approach to fighting cancer.

The patent-pending RPI-Trace3D system was developed by a team led by Badri Roysam, director of the Center for Subsurface Sensing and Imaging Systems (CenSISS) at Rensselaer.

Sophisticated microscopes connected to computers can now generate complex 3-D images to allow scientists to peer deeper inside live tumors. Until recently, such intricate images took days to quantify because scientists had to manually trace the vessels. Typically, the results were less than perfect. The RPI-Trace3D system incorporated into the electronic microscopes identifies and traces all the capillaries of a living tumor in less than two minutes.

The system will significantly improve the search for better cancer-fighting drugs, says Harvard Medical School's Edward Brown, a researcher in the school's Department of Radiation Oncology. Brown is using the mapping system in collaboration with Northeastern University and other schools.

"The Rensselaer research team has generated truly impressive algorithms that trace out all the vessels in a 3-D network, as well as identify a number of properties of the vessels. This allows us to quantify these vessels accurately for the first time," Brown says.

Rensselaer graduate student Muhammad-Amri Abdul-Karim and Rensselaer graduate Khalid Al-Kofahi are key members of the Rensselaer team.

"We are the only cancer research team in the world that uses a rapid, fully automated, tracing algorithm to quickly obtain measurements from 3-D blood vessel images," Abdul-Karim says.

Rensselaer Polytechnic Institute, founded in 1824, is the nation's oldest technological university. The school offers degrees in engineering, the sciences, information technology, architecture, management, and the humanities and social sciences. Institute programs serve undergraduates, graduate students, and working professionals around the world. Rensselaer faculty are known for pre-eminence in research conducted in a wide range of research centers that are characterized by strong industry partnerships. The Institute is especially well known for its success in the transfer of technology from the laboratory to the marketplace so that new discoveries and inventions benefit human life, protect the environment, and strengthen economic development.


Story Source:

The above story is based on materials provided by Rensselaer Polytechnic Institute. Note: Materials may be edited for content and length.


Cite This Page:

Rensselaer Polytechnic Institute. "Branching Out: New System Created By Rensselaer Researchers Speeds The Mapping Of Blood Vessel Networks In Live Tumors." ScienceDaily. ScienceDaily, 27 December 2002. <www.sciencedaily.com/releases/2002/12/021227072952.htm>.
Rensselaer Polytechnic Institute. (2002, December 27). Branching Out: New System Created By Rensselaer Researchers Speeds The Mapping Of Blood Vessel Networks In Live Tumors. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2002/12/021227072952.htm
Rensselaer Polytechnic Institute. "Branching Out: New System Created By Rensselaer Researchers Speeds The Mapping Of Blood Vessel Networks In Live Tumors." ScienceDaily. www.sciencedaily.com/releases/2002/12/021227072952.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins